Baxter International Inc. is a leading manufacturer of recombinant and plasma-derived proteins to treat hemophilia. Baxter markets products with the aim of saving and sustaining lives of people with hemophilia and other chronic medical conditions. Baxter has introduced a number of therapeutic firsts in hemophilia and has the broadest portfolio of hemophilia treatments to help meet individual therapy choices. Baxter focuses on optimizing hemophilia care and investigating possible treatments for a range of bleeding disorders.